Using a Multi-Sensory Device to Help Patients in the Neurosciences ICU
Safety, Feasibility, and Efficacy of a Bio-experiential Intervention, Multi-sensory Intervention Room Application (MIRA), During Neurosciences ICU Stay
This study is testing a new device that uses sound and visuals to see if it can help patients in the Neurosciences ICU recover better after their treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 20 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Icahn School of Medicine at Mount Sinai Academic / other |
| Locations | 1 site (New York, New York) |
| Trial ID | NCT06509815 on ClinicalTrials.gov |
What this trial studies
This research evaluates the safety, feasibility, and efficacy of the MIRA device, a multi-sensory stimulation tool designed to enhance the physical, mental, and cognitive health of patients in the Neurosciences Intensive Care Unit (NSICU). The device utilizes immersive audio and visual experiences to support recovery from Post Intensive Care Syndrome. Participants, including both patients and NSICU staff, will complete questionnaires to assess the device's impact over a 12-month period. The study aims to enroll 20 patients and 15 staff members at Mount Sinai Hospital.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older who are currently admitted to the NSICU at Mount Sinai Hospital and expected to stay for at least 48 hours.
Not a fit: Patients who are not admitted to the Mount Sinai NSICU or do not have a legally authorized representative to provide consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve recovery outcomes for patients suffering from Post Intensive Care Syndrome.
How similar studies have performed: While the use of multi-sensory interventions in critical care settings is emerging, this specific application of the MIRA device is novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: To be eligible to participate in this study, an individual must meet all of the following criteria: For NSICU Staff: * Current employee at NSICU * Aged \>/= 18 For NSICU Patients: * Currently admitted to the Mount Sinai Hospital NSICU for any diagnosis OR a Legally Authorized Representative (LAR) for the patient, and expected to stay for at least 48 hours * Provision of signed and dated informed consent form (ICF) * Stated willingness to comply with all study procedures and availability for the duration of the study * Aged \>/= 18 * Any sex or gender identity * Currently admitted to the Mount Sinai Hospital NSICU for any diagnosis OR a Legally Authorized Representative (LAR) for the patient, and expected to stay for at least 48 hours Exclusion Criteria * Not a Mount Sinai NSICU patient * No LAR present and unable to consent
Where this trial is running
New York, New York
- Mount Sinai Hospital — New York, New York, United States (Recruiting)
Study contacts
- Principal investigator: Neha Dangayach — Principal Investigator
- Study coordinator: Christopher Santiago
- Email: christopher.santiago@mountsinai.org
- Phone: 646-656-4937
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.